Anyone who has dealt with Alzheimer's knows the terrible toll it takes on patients and their families. I watched in horror as my wife’s brilliant, vibrant, extraordinary mother disappeared into the disease in the early 1990s. Alzheimer’s is a cancer-sized problem, and it demands a cancer-sized solution.
A Letter from Our Chairman
NIH research funding for Alzheimer’s is increasing, but not fast enough to address the crisis at hand. While other disease states have decreasing death rates, the Alzheimer’s death rate has increased at a staggering pace. We need increases in research funding to keep up.
A Letter from Our Chairman
Every 65 seconds another family learns a loved one has been diagnosed with Alzheimer’s. I’ve had enough. Join me and demand more funding for Alzheimer’s. Together, we will find a cure. Sincerely, George Vradenburg.
WATCH NOW: UsAgainstAlzheimer's 2018 National Alzheimer's Summit Live Stream
Below you'll find the full suite of sessions from the 2018 National Alzheimer's Summit. That National Alzheimer's Summit took place September 24th- 26th in Washington D.C. Panelists and attendees from
UsAgainstAlzheimer’s Welcomes Eli Lilly Report of Positive Phase III Trial
UsAgainstAlzheimer’s Chairman George Vradenburg issued the following statement regarding the report by Eli Lilly and Company and Avid Radiopharmaceuticals (a subsidiary of Eli Lilly) that flortaucipir, a Positron Emission Tomography imaging
UsAgainstAlzheimer’s Applauds Eisai and Biogen for their Progress Toward a Disease-Modifying Drug
UsAgainstAlzheimer’s Chairman George Vradenburg today issued the following statement regarding the report today by Eisai and Biogen at the Alzheimer’s Association International Conference (AAIC) that their Alzheimer’s Drug BAN2401 demonstrated
This issue brief explores millennial caregiving in the United States with the goal of enhancing our understanding of the experiences and challenges of young adults providing care for a family member or friend living with Alzheimer’s disease or other dementias.
